Although the majority of CTA peptides were only found to be unique in one patient, we identified multiple peptides derived from CTA-associated genes that were present in a substantial portion of patients independent of the tumor entity (e.g. ATAD2, SPAG9, ODF2, and KIAA0100) (Fig. 4d). This evidence concerns the gene SPAG9 and neoplasm.